Ogrinc Katarina, Bogovič Petra, Rojko Tereza, Maraspin Vera, Ružić-Sabljić Eva, Kastrin Andrej, Strle Klemen, Wormser Gary P, Strle Franc
Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Infection. 2025 Jan 2. doi: 10.1007/s15010-024-02461-0.
To determine the frequency of confirmed Lyme neuroborreliosis (LNB) cases in adult patients with three different clinical presentations consistent with early LNB.
Data were obtained through routine health care at the UMC Ljubljana, Slovenia from 2005 to 2022, using clinical pathways. The patients were classified into three groups: (i) radicular pain of new onset (N = 332); or (ii) involvement of cranial nerve(s) but without radicular pain (N = 997); or (iii) erythema migrans (EM) skin lesion(s) in conjunction with symptoms suggestive of nervous system involvement but without either cranial nerve palsy or radicular pain (N = 240). The diagnosis of LNB considered the following variables: the presence of: (1) neurologic symptoms consistent with LNB (with no other obvious explanation); (2) cerebrospinal fluid (CSF) pleocytosis (> 5 × 10 leukocytes/L); and (3) demonstration of intrathecal synthesis of borrelial antibodies, and/or cultivation of borrelia from CSF, and/or the presence of EM. Patients fulfilling only the first two criteria were interpreted as having possible LNB, while those who satisfied all three criteria were regarded as having confirmed LNB.
Of 1569 adult patients, 348 (22.2%) had confirmed LNB and 70 (4.5%) others had possible LNB. The proportion of confirmed LNB cases was the highest for patients with radicular pain (217/332, 65.4%), followed by the group with EM and neurologic symptoms (47/240, 19.6%), and those with cranial neuritis (84/997, 8.4%).
Only 22% of patients evaluated had confirmed LNB. The proportion of confirmed LNB cases correlated with clinical presentation and was highest among patients with recent onset of radicular pain.
确定具有三种与早期莱姆病神经伯氏疏螺旋体病(LNB)相符的不同临床表现的成年患者中确诊的LNB病例的频率。
通过2005年至2022年在斯洛文尼亚卢布尔雅那大学医学中心的常规医疗保健,利用临床路径获取数据。患者被分为三组:(i)新发神经根性疼痛(N = 332);或(ii)累及颅神经但无神经根性疼痛(N = 997);或(iii)游走性红斑(EM)皮肤病变并伴有提示神经系统受累的症状,但无颅神经麻痹或神经根性疼痛(N = 240)。LNB的诊断考虑以下变量:存在:(1)与LNB相符的神经症状(无其他明显解释);(2)脑脊液(CSF)淋巴细胞增多(> 5×10白细胞/L);以及(3)鞘内伯氏疏螺旋体抗体合成的证明,和/或从CSF中培养出伯氏疏螺旋体,和/或存在EM。仅满足前两个标准的患者被解释为可能患有LNB,而满足所有三个标准的患者被视为确诊为LNB。
在1569名成年患者中,348例(22.2%)确诊为LNB,另外70例(4.5%)可能患有LNB。确诊LNB病例的比例在有神经根性疼痛的患者中最高(217/332,65.4%),其次是有EM和神经症状的组(47/240,19.6%),以及有颅神经炎的组(84/997,8.4%)。
接受评估的患者中只有22%确诊为LNB。确诊LNB病例比例与临床表现相关,在近期新发神经根性疼痛的患者中最高。